TY - JOUR
T1 - IL-6 Antibody and RGD Peptide Conjugated Poly(amidoamine) Dendrimer for Targeted Drug Delivery of HeLa Cells
AU - Mekuria, Shewaye Lakew
AU - Debele, Tilahun Ayane
AU - Chou, Hsiao Ying
AU - Tsai, Hsieh Chih
N1 - Publisher Copyright:
© 2015 American Chemical Society.
PY - 2016/1/14
Y1 - 2016/1/14
N2 - In this study, PAMAM dendrimer (G4.5) was conjugated with two targeting moieties, IL-6 antibody and RGD peptide (G4.5-IL6 and G4.5-RGD conjugates). Doxorubicin anticancer drug was physically loaded onto G4.5-IL6 and G4.5-RGD with the encapsulation efficiency of 51.3 and 30.1% respectively. The cellular internalization and uptake efficiency of G4.5-IL6/DOX and G4.5-RGD/DOX complexes was observed and compared by confocal microscopy and flow cytometry using HeLa cells, respectively. The lower IC50 value of G4.5-IL6/DOX in comparison to G4.5-RGD/DOX is indication that higher drug loading and faster drug release rate corresponded with greater cytotoxicity. The cytotoxic effect was further verified by increment in late apoptotic/necrotic cells due to delivery of drug through receptor-mediated endocytosis. On the basis of these results, G4.5-IL6 is a better suited carrier for targeted drug delivery of DOX to cervical cancer cells.
AB - In this study, PAMAM dendrimer (G4.5) was conjugated with two targeting moieties, IL-6 antibody and RGD peptide (G4.5-IL6 and G4.5-RGD conjugates). Doxorubicin anticancer drug was physically loaded onto G4.5-IL6 and G4.5-RGD with the encapsulation efficiency of 51.3 and 30.1% respectively. The cellular internalization and uptake efficiency of G4.5-IL6/DOX and G4.5-RGD/DOX complexes was observed and compared by confocal microscopy and flow cytometry using HeLa cells, respectively. The lower IC50 value of G4.5-IL6/DOX in comparison to G4.5-RGD/DOX is indication that higher drug loading and faster drug release rate corresponded with greater cytotoxicity. The cytotoxic effect was further verified by increment in late apoptotic/necrotic cells due to delivery of drug through receptor-mediated endocytosis. On the basis of these results, G4.5-IL6 is a better suited carrier for targeted drug delivery of DOX to cervical cancer cells.
UR - http://www.scopus.com/inward/record.url?scp=84955300737&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955300737&partnerID=8YFLogxK
U2 - 10.1021/acs.jpcb.5b11125
DO - 10.1021/acs.jpcb.5b11125
M3 - Article
C2 - 26670944
AN - SCOPUS:84955300737
SN - 1520-6106
VL - 120
SP - 123
EP - 130
JO - Journal of Physical Chemistry B
JF - Journal of Physical Chemistry B
IS - 1
ER -
